LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 43.65 | 21.74 | 2293 | 3754 | 0.6108 | 0.8716 | MN20160310_N01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 43.65 | 21.74 | 2470 | 3754 | 0.6579 | 0.8905 | MN20160310_N01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 43.65 | 21.74 | 2584 | 3754 | 0.6883 | 0.9020 | MN20160310_N01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 43.65 | 21.74 | 2598 | 3754 | 0.6920 | 0.9034 | MN20160310_N01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 43.65 | 21.74 | 131 | 3754 | 0.0349 | 0.2734 | MN20160310_N01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 43.65 | 21.74 | 2944 | 3754 | 0.7842 | 0.9356 | MN20160310_N01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 45.62 | 21.74 | 2524 | 4150 | 0.6081 | 0.8729 | MN20160310_N01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 45.62 | 21.74 | 2634 | 4150 | 0.6346 | 0.8835 | MN20160310_N01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 45.62 | 21.74 | 2767 | 4150 | 0.6666 | 0.8958 | MN20160310_N01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 45.62 | 21.74 | 2780 | 4150 | 0.6697 | 0.8969 | MN20160310_N01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 45.62 | 21.74 | 164 | 4150 | 0.0395 | 0.3056 | MN20160310_N01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 45.62 | 21.74 | 3161 | 4150 | 0.7615 | 0.9294 | MN20160310_N01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 47.59 | 21.74 | 2798 | 4492 | 0.6229 | 0.8806 | MN20160310_N01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 47.59 | 21.74 | 2880 | 4492 | 0.6411 | 0.8877 | MN20160310_N01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 47.59 | 21.74 | 2952 | 4492 | 0.6572 | 0.8938 | MN20160310_N01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 47.59 | 21.74 | 2966 | 4492 | 0.6603 | 0.8949 | MN20160310_N01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 47.59 | 21.74 | 173 | 4492 | 0.0385 | 0.3096 | MN20160310_N01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 47.59 | 21.74 | 3420 | 4492 | 0.7613 | 0.9303 | MN20160310_N01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 49.56 | 21.74 | 3072 | 4838 | 0.6349 | 0.8868 | MN20160310_N01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 49.56 | 21.74 | 3139 | 4838 | 0.6487 | 0.8920 | MN20160310_N01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 49.56 | 21.74 | 3143 | 4838 | 0.6495 | 0.8923 | MN20160310_N01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 49.56 | 21.74 | 3161 | 4838 | 0.6533 | 0.8937 | MN20160310_N01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 49.56 | 21.74 | 249 | 4838 | 0.0515 | 0.3671 | MN20160310_N01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 49.56 | 21.74 | 3669 | 4838 | 0.7583 | 0.9303 | MN20160310_N01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 51.53 | 21.74 | 3251 | 5150 | 0.6312 | 0.8867 | MN20160310_N01 | E20 |